ClinicalTrials.gov
public full text
Public Domain
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
The purpose of this study is to provide data on the proportion of seroconverted children and their immune status. It will also provide insight into the number of children currently infected at each time point including healthy carriers. Investigators will provide similar data on their parents in an ancillary study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children#1112535
- Influenza Vaccine in HIV Infected Children#914224
- Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)#208276
- Cohort profile: the SEROCoV-KIDS population-based cohort study and biobank on the impact of the COVID-19 pandemic in children and adolescents in Geneva, Switzerland#1133292
- Seroprevalence of SARS-Cov-2 Antibodies in Children#835980
Record · ID 864909
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive